Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
7.13
-0.17 (-2.33%)
At close: Mar 20, 2026, 4:00 PM EDT
7.05
-0.08 (-1.12%)
Pre-market: Mar 23, 2026, 5:36 AM EDT

Kyntra Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6.4429.6246.8140.73235.31
Revenue Growth (YoY)
-78.26%-36.71%-66.74%-40.19%33.46%
Cost of Revenue
0.5615.563.9620.2812.87
Gross Profit
5.8814.0642.84120.45222.44
Selling, General & Admin
27.7149.3386.48124.69123.93
Research & Development
23.5295.69266.47296.79387.04
Other Operating Expenses
0.5519.4512.61--
Total Operating Expenses
51.78164.48365.56421.48510.97
Operating Income
-45.9-150.42-322.72-301.03-288.53
Interest Income
2.945.37.599.17-0.07
Interest Expense
-8.76-8.25-8.1-1.44-1.08
Other Non-Operating Income (Expense)
-6.58----
Total Non-Operating Income (Expense)
-12.4-2.95-0.57.73-1.15
Pretax Income
-58.29-153.37-323.22-294.87-290.68
Provision for Income Taxes
0.090.270.25-0.36-0.35
Net Income
183.45-47.58-284.23-293.65-290.02
Earnings From Discontinued Operations
241.66105.5238.74--
Net Income to Common
183.45-47.58-284.23-293.65-290.02
Shares Outstanding (Basic)
44444
Shares Outstanding (Diluted)
44444
Shares Change (YoY)
1.02%2.82%3.98%1.33%2.78%
EPS (Basic)
45.37-11.89-73.00-78.50-78.50
EPS (Diluted)
45.37-11.89-73.00-78.50-78.50
Free Cash Flow
-4.81-138.27-317.54-149.67-87.42
Free Cash Flow Per Share
-1.19-34.55-81.59-39.98-23.67
Gross Margin
91.37%47.47%91.53%85.59%94.53%
Operating Margin
-712.66%-507.80%-689.53%-213.90%-122.62%
Profit Margin
-903.79%-516.86%-690.06%-209.27%-123.38%
FCF Margin
-74.72%-466.78%-678.46%-106.35%-37.15%
EBITDA
-45.15-147.72-312.79-290.42-273.72
EBITDA Margin
-701.04%-498.71%-668.31%-206.36%-116.32%
EBIT
-45.9-150.42-322.72-301.03-288.53
EBIT Margin
-712.66%-507.80%-689.53%-213.90%-122.62%
Effective Tax Rate
-0.15%-0.18%-0.08%0.12%0.12%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.